Antimicrobial resistance and bacterial virulence;Resistencia a los antimicrobianos y virulencia bacteriana

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 23, Issue 2, 2005, Pages 86-93

  Linares Rodríguez, Juan Francisco ^a   Martínez Menéndez, José Luis ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Antimicrobial agents; Efflux pumps; Resistance; Virulence

Indexed keywords

ANTIBIOTIC AGENT; ISONIAZID; MULTIDRUG RESISTANCE PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTAMINATION; ECOSYSTEM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFECTION RISK; MULTIDRUG RESISTANCE; NONHUMAN; OPPORTUNISTIC INFECTION; PHENOTYPE; PLASMID; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; RISK FACTOR;

EID: 16844381060     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13071612     Document Type: Review

References (48)

1. Quinn JP. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin Infect Dis 1998;27:S117-24.
2. Swartz MN. Hospital-acquired infections: diseases with increasingly limited therapies. Proc Natl Acad Sci USA 1994;91:2420-7.
3. Segal S, Hill AV. Genetic susceptibility to infectious disease. Trends Microbiol 2003;11:445-8.
4. Palumbi SR. Humans as the world's greatest evolutionary force. Science 2001;293:1786-90.
5. Martínez JL, Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 2002;15:647-79.
6. Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr Opin Microbiol 1999;2:489-93.
7. Beck MA, Handy J, Levander OA. Host nutritional status: the neglectedvirulence factor. Trends Microbiol 2004;12:417-23.
8. Martínez JL, Blázquez J, Baquero F. Non-canonical mechanisms of antibiotic resistance. Eur J Clin Microbiol Infect Dis 1994;13:1015-22.
9. Monack DM, Theriot JA. Actin-based motility is sufficient for bacterial membrane protrusion formation and host cell uptake. Cell Microbiol 2001;3:633-47.
10. Seral C, Van Bambeke F, Tulkens PM. Quantitative analysis of gentamicin, azithromycin, telithromycm, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. Antimicrob Agents Chemother 2003;47:2283-92.
11. Dargis M, Gourde P, Beauchamp D, Foiry B, Jacques M, Malouin F. Modification in penicillin-binding proteins during in vivo development of genetic competence of Haemophilus influenzae is associated with a rapid change in the physiological state of cells. Infect Immun 1992;60:4024-31.
12. Barker J, Scaife H, Brown MR. Intraphagocytic growth induces an antibiotic-resistant phenotype of Legionella pneumophila. Antimicrob Agents Chemother 1995;39:2684-8.
13. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003;426:306-10.
14. Borriello G, Werner E, Roe F, Kim AM, Ehrlich GD, Stewart PS. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 2004;48:2659-64.
15. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999;37:1771-6.
16. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs 2004;64:159-204.
17. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol 1995;16:45-55.
18. Lacroix FJ, Cloeckaert A, Grepinet O, Pinault C, Popoff MY, Waxin H, et al. Salmonella typhimurium acrB-like gene: identification and role in resistance to biliary salts and detergents and in murine infection. FEMS Microbiol Lett 1996;135:161-7.
19. Lin J, Sahin O, Michel LO, Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 2003;71:4250-9.
20. Jerse AE, Sharma ND, Simms AN, Crow ET, Snyder LA, Shafer WM. A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect Immun 2003;71:5576-82.
21. Lee EH, Shafer WM. The farAB-encoded efflux pump mediates resistance of gonococci to long-chained antibacterial fatty acids. Mol Microbiol 1999;33:839-45.
22. Smith RS, Iglewski BH. P. aeruginosa quorum-sensing systems and virulence. Curr Opin Microbiol 2003;6:56-60.
23. Kohler T, Van Delden C, Curty LK, Hamzehpour MM, Pechere JC. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J Bacteriol 2001;183:5213-22.
24. Evans K, Passador L, Srikumar R, Tsang E, Nezezon J, Poole K. Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. J Bacteriol 1998;180:5443-7.
25. Aendekerk S, Ghysels B, Cornells P, Baysse C. Characterization of a new efflux pump, MexGHI-OpmD, from Pseudomonas aeruginosa that confers resistance to vanadium. Microbiology 2002;148:2371-81.
26. Barbosa TM, Levy SB. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol 2000;182:3467-74.
27. Alonso A, Sánchez P, Martínez JL. Environmental selection of antibiotic resistance genes. Environ Microbiol 2001;3:1-9.
28. Enne VI, Livermore DM, Stephens P, Hall LM. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 2001;357:1325-8.
29. Martínez JL, Baquero F. Genetic linkage of antibiotic resistance and bacterial virulence. APUA Newsletters 1988;6:1-3.
30. Kollef MH. Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med 2001;29:N135-42.
31. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counter selection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 1999;43:2131-7.
32. Bjorkman J, Nagaev I, Berg OG, Hughes D, Andersson DI. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 2000;287:1479-82.
33. Enne VI, Bennett PM, Livermore DM, Hall LM. Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure. J Antimicrob Chemother 2004;53:958-63.
34. Aarestrup FM, Seyfarth AM, Emborg HD, Pedersen K, Hendriksen RS, Eager F. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 2001;45:2054-9.
35. Alonso A, Morales G, Escalante R, Campanario E, Sastre L, Martínez JL. Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology. J Antimicrob Chemother 2004;53:432-4.
36. Cosson P, Zulianello L, Join-Lambert O, Faurisson F, Gebbie L, Benghezal M, et al. Pseudomonas aeruginosa virulence analyzed in a Dictyostelium discoideum host system. J Bacteriol 2002;184:3027-33.
37. Sánchez P, Linares JF, Ruiz-Díez B, Campanario E, Navas A, Baquero F, et al. Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J Antimicrob Chemother 2002;50:657-64.
38. Zhang Y, Heym B, Allen B, Young D, Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992;358:591-3.
39. Li Z, Kelley C, Collins F, Rouse D, Morris S. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J Infect Dis 1998;177:1030-5.
40. Pym AS, Saint-Joanis B, Cole ST. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun 2002;70:4955-60.
41. Sherman DE, Mdluli K, Hickey MJ, Arain TM, Morris SL, Barry CE, et al. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 1996;272:1641-3.
42. Evans DJ Jr, Evans DG. Colonization factor antigens of human pathogens. Curr Top Microbiol Immunol 1990;151:129-45.
43. Martínez JL, Baquero F. Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother 2000;44:1771-7.
44. Davies JE. Origins, acquisition and dissemination of antibiotic resistance determinants. Ciba Found Symp 1997;207:15-27.
45. Oliver A, Cantón R, Campo P, Baquero F, Blázquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000;288:1251-4.
46. Salyers AA, Gupta A, Wang Y. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 2004;12:412-6.
47. Alonso A, Rojo F, Martínez JL. Environmental and clinical isolates of Pseudomonas aeruginosa show pathogenic and biodegradative properties irrespective of their origin. Environ Microbiol 1999;1:421-30
48. Crisostomo MI, Westh H, Tomasz A, Cheng M, Oliveira DC, De Lencastre H. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci USA 2001;98:9865-70.